Table 3 Meta-analysis results for the association between GHET1 expression and clinicopathological characteristics
From: Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis
Variables | Studies (n) | Patient (n) | Pooled OR (95% CI) | PHet | I2 (%) | P | Model |
|---|---|---|---|---|---|---|---|
Age (old: young) | 15 | 1235 | 0.915 [0.725, 1.154] | 0.608 | 0.0 | 0.452 | Fixed |
Gender (male: female) | 13 | 1081 | 0.987 [0.750, 1.299] | 0.828 | 0.0 | 0.925 | Fixed |
Tumor size (large: small) | 13 | 1143 | 2.794 [2.197, 3.554] | 0.101 | 35.2 | < 0.001 | Fixed |
Differentiation (poor: well) | 12 | 1010 | 1.266 [0.671, 2.388] | 0.000 | 77.4 | 0.467 | Random |
Lymph node metastasis (yes: no) | 9 | 596 | 4.018 [2.816, 5.734] | 0.151 | 33.4 | < 0.001 | Fixed |
Distant metastasis (yes: no) | 6 | 342 | 3.994 [2.028, 7.864] | 0.296 | 18.1 | < 0.001 | Fixed |
TNM stage (III/IV: I/II) | 13 | 1125 | 3.721 [2.889, 4.793] | 0.336 | 10.9 | < 0.001 | Fixed |